Silent Theatre presentations

Programme stream(s): Silent theatre
Programme session type(s): No session type

12:40-13:55

Room: Silent theatre 2 - Hall 4

These theatres provide an area for accepted abstract submitters to present their research in 5 minute presentations.

The abstract presentations in this session are:

12.40 – Angelina Kurniati, Process mining to explore variation in chemotherapy pathways for breast cancer patients

12. 46 – Benjamin Jefferies, Variation in surgical practices of oesophagectomy for oesophageal cancers: A unit survey of the Oesophagogastric Anastomosis Audit (OGAA)

12.52 – Krishna Yalla, Developing Pharmacodynamic Biomarkers for Monitoring Response to Cdc7 Inhibitors in Patients

12.58 – Vinodh Kannappan, Disulfiram suppresses malignant mesothelioma in vitro and in vivo by targeting hypoxia induced NF-kB pathway and cancer stem cells

13.04 – Wing Kin Liu, A Single Centre Study to Assess Outcomes and Toxicity Profiles in Patients with Non-Small Cell Lung Cancer Receiving Pembrolizumab Therapy

13.10 – Nimesh Jayasuriya, Does the 8th Edition UICC staging Offer a Prognostic Advantage in Oropharyngeal Squamous Cell Carcinomas?

13.16 – Mercy Ofuya, Clinical trial methodology in evaluating the benefits of proton beam therapy: a systematic review

13:22 – Suzanne Riches, A novel high-throughput multi-parametric drug screening method for 3D tumor spheroids using Celigo image cytometer

13.28 – Alan Bilsland, An exploratory study on the use of game-based learning using Microsoft Kinect to teach oncology phase I clinical trial designs

13.34 – John Timms, Longitudinal and Network Serum Biomarker Models for Early Detection of Ovarian Cancer

13.40 – Dorothy Yang, Systemic Anti-Cancer Therapy (SACT) in elderly patients with urological malignancy

13.46 – Wladyslaw Januszewicz, Safety and acceptability of a non-endoscopic oesophageal sampling device – Cytosponge®: A systematic review of multi-centre data